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Abstract 
 
Background: Reports on agmatine are controversial showing that it may improve memory, it can deteriorate 
memory and some did not notice any interference with learning and memory. In the present study, the effect of 
directly intra-CA1 agmatine microinjection on water maze learning and memory has been assessed.  
 
Methods: The cannuls were implanted in hippocampal CA1 regions of rats in a sterotaxic frame after general 
anesthesia. After one week recovery period, the animals were assessed in the reference memory version of 
water maze. Agmatine (1, 10, 100 or 200 µg/0.5 µl) or saline were infused 20 minutes before or immediately after 
training.  
 
Results: Agmatine-treated rats did not show any significant difference neither in water maze acquisition nor in 
consolidation task in comparison with control and sham groups.  
 
Conclusion: Agmatine does not affect water maze learning and memory. 
Keywords: Agmatine; Water maze; Learning; Memory; Hippocampus; CA1; Rat 
 
 
Introduction 
 
Agmatine (4-aminobutyl guanidine) is one of the me-
tabolites  of  L-arginine.  It  is  synthesized  by  arginine 
decarboxylase (ADC) and hydrolyzed by agmatinase.
1 
Although for a long time, it was considered as a con-
stituent of bacteria, plants and invertebrates, later evi-
dences suggested that agmatine exists also in mamma-
lian tissues including brain.
2-4 It is widely distributed in 
the brain and its concentration is similar to the other 
neurotransmitters concentrations.
3-5 Because agmatine 
is synthesized in the brain, stored in synaptic vesicles, 
accumulated by uptake, released by depolarization and 
inactivated by agmatinase, it is considered to be a puta-
tive neurotransmitter.
6 
There are some evidences that agmatine modulate 
learning and memory. For example, agmatine (ip) has 
been reported to impair contextual fear conditioning 
and learning, but did not have any effect on water 
maze performance.
7,8 Arteni et al.
9 showed that ag-
matine (ip) facilitated animal's performance in inhibi-
tory  avoidance  task.  Intracerebroventricularly  (icv) 
administered agmatine has been reported to modulate 
water  maze  reference  memory  dose-dependently;  it 
improved memory at low dose (10 µg), but impaired 
it at a low dose (100 µg).
10 One of the brain structures 
which has an essential role in the processing of spatial 
learning is the hippocampus. The CA1 subregion as 
the last station of hippocampal neural loops, is specif-
ically  involved  in  spatial  learning  and  memory.
11 
Agmatine-like immunoreactivity has been detected in 
axon terminals of CA1 area, synapsing with pyrami-
dal cells.
12 This agmatine is suggested to be co-stored 
with glutamate in hippocampal synaptic vesicles.
5 In 
hippocampal slices, agmatine superfusion  decreases 
CA1 neural discharges.
13 In contrast, it is demonstrat-
ed  that  CA1  agmatine  level  increases  after  water 
maze spatial learning.
14 
Knowing the important role of CA1 region in hip-
pocampal function, existence of agmatine in this area 
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and the inconsistency of previous experiments regard-
ing  agmatine  effect  on  hippocampal  function,  we 
aimed to target CA1 region to assess if agmatine can 
affect  its  function  considering  that  intra-CA1  ag-
matine administration allows us to assess agmatine's 
direct effect on CA1 area with the least contribution 
of the other brain regions.  
 
 
Materials and Methods 
 
Male Sprague-Dawely rats (200–250 g at the time of 
surgery) were obtained from Laboratory Animal Cen-
ter of Shiraz University of Medical Sciences. The an-
imals were housed four per cage before surgery and 
two per cage after surgery in a constant temperature 
(24±1°C) and humidity controlled room, under a 12-
12h light/dark cycle. Food and water were provided 
ad  libitum  except  for  the  periods  of  experimental 
studies  in  water  maze.  The  behavioral  experiments 
were  done  during  the  light  phase.  All  experiments 
were carried out in accordance with recommendations 
from the Declaration of Helsinki and the internation-
ally accepted principles for the use of experimental 
animals.  Agmatine  was  purchased  from  Sigma  (St. 
Louis, USA) and was diluted in sterile isotonic saline. 
Animals were anesthetized with a combination of 
ketamine  (100 mg/kg,  ip)  and  xylazine  (2.5 mg/kg, 
ip) and placed in a stereotaxic apparatus (Stoelting, 
USA). Stainless steel guide cannulae (22-gauge) were 
bilaterally implanted in the CA1 region with the fol-
lowing coordinates according to the rat brain atlas of 
Paxinos  and  Watson:
15  AP−3.84 mm  from  bregma, 
ML±2.2 mm  from  midline,  DV−2.6 mm  from  the 
skull surface. The incisor  bar was lowered  3.3 mm 
below horizontal zero to achieve the flat skull posi-
tion.  The  cannulae  were  fixed  to  the  skull  surface 
with two stainless screws and dental acrylic cement. 
After  surgery,  all  animals  were  allowed  a  1-week 
post-operative  recovery  period  before  initiation  of 
behavioral experiments. 
Saline or drug were administered into CA1 region 
bilaterally,  through  guide  cannula  (22-gauge)  using 
injection needles (27-gauge) connected by a piece of 
polyethylene tube to a 10 µl Hamilton syringe. The 
tip of the injection needle was protruded 0.5 mm be-
yond the guide cannula tip and in each microinjection 
0.5 μl saline or drug was infused within 2 minutes. 
After completion of the infusion, the needle was left 
in place for another 60 seconds to allow diffusion of 
the drugs from the needle. 
The water maze has been described previously.
16 
Briefly it was a black circular pool with a diameter of 
140 cm and a height of 70 cm, filled with 25±1°C 
water to a depth of 25 cm. The maze was divided 
geographically into four equal quadrants and release 
points that were designed at each quadrant as N, E, S, 
and  W.  A  hidden  circular  platform  (11  cm  in 
diameter), was located in the center of the southwest 
quadrant and submerged 1.5 cm beneath the surface 
of  the  water.  Fixed,  extra  maze  visual  cues  were 
present  at  various  locations  around  the  maze  (i.e. 
computer, a door, a window, bookshelves, posters). A 
CCD camera was mounted above the center of the 
maze so that the animal motion could be recorded and 
sent to the computer. The path of animal's swimming 
was automatically recorded by a computerized system 
(Noldus EthoVision, version 3.1) and then analyzed 
by computing several parameters, e.g. latency to find 
the  platform,  traveled  distance  as  well  as  the 
swimming speed. 
Experiment 1: The aim of experiment 1 was to 
determine  the  effect  of  bilateral  pre-training 
injection  of  agmatine  into  CA1  region  on  water 
maze place learning. The rats were divided into 7 
groups  (n=7);  four  groups  received  bilateral 
injections  of  agmatine  into  CA1  area,  20  minutes 
before training in doses 1, 10, 100 and 200 µg/0.5 
µl, the sham group received saline as vehicle (0.5 µl 
bilaterally) and the control group received nothing. 
In  order  to  assess  our  water  maze  sensitivity,  a 
positive control group receiving scopolamine in dose 
1 mg/kg/ip- which previous studies had showed its 
memory  impairing  effect,  was  considered  in  the 
experiment.  The  time  interval  of  20  minutes  was 
selected according to previous reports.
8 
One week after surgery and 20 minutes after saline 
or drug administration, the rats were trained in the 
water maze. Animals received four session training 
during four daily sessions;
17 each session consisted of 
four trials. During the first 3 days, the platform, situ-
ated  in  the  center  of  the  southwest  quadrant,  was 
submerged  1.5 cm  below  the  surface  of  water  and 
therefore invisible,  for  testing spatial  learning.  The 
platform  position  remained  stable  over  3  days  and 
acquisition of this task was assessed. On day 4, the 
platform  was  elevated  above  water  level,  covered 
with a piece of aluminum foil and placed in the center 
of the southeast quadrant. This task was designed to 
assess animal’s motivation and sensorimotor coordi-
nation towards a visible platform. A trial was started 
by placing a rat in the pool and facing the wall of the Rastegar et al. 
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tank.  Each  of  four  starting  positions  (north,  east, 
south and west) was used once in a series of four 
trials and their orders were randomized. Each trial 
was terminated when the rat found and climbed onto 
the escape platform or when 60 s had elapsed. A rat 
was allowed to stay on the platform for 20 s; then 
the next trial was started. The animals which did not 
find the platform within 60 s, were put on the plat-
form by the experimenter and were allowed to stay 
there for 20 s. After completion of the 4th trial, rats 
were gently dried with a towel and returned back to 
their home cage.  
Experiment 2: The aim of experiment 2 was to de-
termine  the  effect  of  bilateral  post-training  admin-
istration of agmatine into CA1 region on water maze 
memory  consolidation.  The  rats  were  randomly  di-
vided into 7 groups (n=7); four groups received bilat-
eral injections of agmatine into CA1 area, immediate-
ly after training in doses 1, 10, 100 and 200 µg/0.5 µl, 
the sham group received saline as vehicle (0.5 µl bi-
laterally) and the control group which received noth-
ing. In order to assess our water maze sensitivity, a 
positive control group receiving scopolamine in dose 
1 mg/kg/ip was put in the experiment. 
One week after surgery, the rats were trained in 
the water maze. The single training session consisted 
of  eight  trials  with  four  different  starting  positions 
that were equally distributed around the perimeter of 
maze.
16 The task requires rats to swim to the hidden 
platform guided by distal cues. After mounting the 
platform, the rats were allowed to remain there for 20 
s and were then placed in a holding cage for 30 s until 
the start of the next trial. The animals were given a 
maximum of 60 s to find the platform; if they failed 
to find the platform in this time, they would be placed 
by the experimenter on the platform and allowed to 
stay there for 20 s. After completion of the training, 
the animals returned to their home cage until the re-
tention testing (probe trial) 24 hours later. The probe 
trial consisted of a 60 s free swim period without a 
platform and the time spent in the target quadrant was 
recorded. Immediately after probe trial, the animals 
were given four trials for visuo-motor coordination on 
the visible platform. 
At the completion of the memory test, animals 
were anesthetized with ether, decapitated and their 
brains were removed and stored in 10% formalin. 
After  2  days,  the  brain  sections  were  prepared, 
mounted on slides, and cannulae placements were 
examined for verification of needle tip locations. 
Animals  were  included  for  data  analysis  only  if 
both  needle  placements  were  located  within  the 
CA1 region. 
Data  were  expressed  as  the  mean±SEM.  An 
analysis of variance (ANOVA) followed by Student, 
Newman-Keuls multiple comparison tests was used 
for statistical comparison. In all cases, a p value of 
less than 0.05 was considered statistically significant. 
 
 
Results 
 
Figure 1A shows the results obtained from daily pre-
training infusion of saline or agmatine into CA1 area 
of the hippocampus on the escape latency to the hid-
den platform. Repeated measure ANOVA of the es-
cape latency showed that pre-training intra-CA1 ag-
matine administration (1, 10, 100 and 200 µg) did not 
affect escape latency significantly in none of 3 days 
training in comparison to the respective days in saline 
treated  and  control  group.  However  scopolamine-
treated group significantly took longer time to reach 
the platform in comparison with saline and control 
group in those respective days.  
Figure  1B  shows  the  results  obtained  from  pre-
training infusion of saline or agmatine into CA1 area 
of the hippocampus on the traveled distance to the 
hidden platform. Repeated measure ANOVA of the 
escape  latency  showed  that  pre-training  intra-CA1 
agmatine administration (1, 10, 100 and 200 µg) did 
not affect traveled distance significantly in none of 3 
days training in comparison to the respective days in 
saline treated and control group. However scopola-
mine  increased  this  parameter  in  comparison  with 
saline and control group in those respective days.  
Figure 1C shows the learning pattern of the ani-
mals treated with saline or agmatine or scopolamine. 
This figure shows that there is a negative linear corre-
lation between escape latency and the training ses-
sions in all groups. This means that all groups have 
learnt  the  platform  location;  however  scopolamine 
has slowed down learning capability. 
Figure  2  shows  the  results  obtained  from  post-
training infusion of saline or agmatine into CA1 area 
of  the  hippocampus  on  memory  consolidation  in 
probe test. Post-training intra-CA1 agmatine admin-
istration (1, 10, 100 and 200 µg) did not affect the 
time animals spent in target quadrant in comparison 
to saline treated and control group although scopola-
mine treatment has decreased that. The data derived 
from  single  training  session  showed  no  difference 
between groups (data not shown). Microinjection of intra-CA1 agmatine 
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Fig. 1A-C: The effect of pre-training agmatine, saline or scopolamine administration on escape latency to the invisi-
ble platform during learning sessions (Fig. 1A); The effect of pre-training agmatine, saline or scopolamine admin-
istration on traveled distance to the invisible platform during learning sessions (Fig. 1B); and the learning patterns of 
the animals during learning sessions (Fig. 1C). Data are represented as mean±SEM. ** P<0.01 reveals significant 
difference between scopolamine treated and saline or control group. 
 
0
5
10
15
20
25
30
35
40
control sham 1 10 100 200 Scopolamine
T
i
m
e
 
s
p
e
n
t
 
i
n
 
t
a
r
g
e
t
 
q
u
a
d
r
a
n
t
 
(
s
)
Agmatine (µg)
**
 
Fig. 2: The effect of post-training agmatine, saline or scopolamine administration on the time traveled in target 
quadrant in probe test. The columns represent mean±SEM. ** P<0.01 reveals significant difference between sco-
polamine treated and saline or control group. 
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  The effect of pre- or post-training infusion of sa-
line or agmatine into CA1 area of the hippocampus 
on the swimming speed of animals (data were aver-
aged to obtain a mean performance of the groups) is 
depicted in Table 1. One way ANOVA of the mean 
animal’s  swimming  speed  showed  that  intra-CA1 
agmatine administration (1, 10, 100 and 200 µg) did 
not affect swimming speed significantly in compari-
son  to  saline  treated  group.  Scopolamine  treatment 
did not also affect the animal’s swimming speed in 
comparison to saline and control group. 
The effect of pre- or post-training infusion of sa-
line or agmatine into CA1 area of the hippocampus 
on the escape latency to the visible platform is depict-
ed in Table 2. One way ANOVA of the escape laten-
cy showed that intra-CA1 agmatine administration (1, 
10, 100 and 200 µg) did not affect escape latency to 
the  visible  platform  significantly  in  comparison  to 
saline treated group. Also scopolamine treatment did 
not affect the escape latency to visible platform  in 
comparison to saline and control group. 
Discussion 
 
Our findings in the present study indicate that i) Pre-
training intra-CA1 administration of 1, 10, 100 and 
200 µg agmatine had no effect on water maze place 
learning, ii) Post-training intra-CA1 administration of 
agmatine in doses 1, 10, 100 and 200 µg could not 
affect water maze memory consolidation, iii)  Intra-
CA1 agmatine administration did not affect animal's 
swimming speed and iv) Intra- CA1 agmatine admin-
istration did not affect the escape latency to the visible 
platform in non-spatial visual discrimination task. 
Agmatine did not affect animal's swimming speed 
or  its  motivation  toward  visible  platform,  showing 
that it does not affect animal's sensorimotor coordi-
nance. Pre- or post-training administration of scopol-
amine (1 mg/kg/ip) could impair water maze learning 
and memory, which confirms our water maze system 
sensitivity.  Agmatine  was  administered  20  minutes 
before each training episode, the time interval which 
previous studies reported some impairing effects after 
Table 1: The effect of pre-training and post-training agmatine, saline or scopolamine administration on animal’s 
swimming speed. 
Group  Control  Saline    Agmatine (µg)    Scopolamine 
  1  10  100  200 
pre-training 
Mean 
Speed 
(cm/s) 
22.9  23.7  23.9  22.5  22.4  23.3  21.8 
SEM  1  0.7  1.084  0.6064  1.595  1.2  1.77 
post-training 
Mean 
Speed 
(cm/s) 
25.5  25.8  26  24.75  24  26.6  24.2 
SEM  1.9  1.68  1.65  1.03  1.27  1.25  1.3 
 
 
Table 2:The effect of pre-training and post-training agmatine, saline or scopolamine administration on animal’s 
escape latency to the visible platform. 
Group  Control  Saline    Agmatine (µg)    Scopolamine 
  1  10  100  200 
pre-training               
Escape Latency 
(S) 
14.5  15.75  16.7  16.3  17.1  15.8  16.3 
SEM  3.1  2.9  1.85  3.3  1.9  2.95  1.4 
post-training 
Escape Latency 
(S) 
13.75  14.85  14.8  15.1  15.4  15.9  16.3 
SEM  2.9  3.1  1.98  3.2  2.7  2.8  2.9 
 Microinjection of intra-CA1 agmatine 
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its intraperitoneal injection.
8 Pre-training agmatine ad-
ministration was used to assess the effect of this drug on 
acquisition and possibly the consolidation process as the 
consolidation  process  of  memory  starts  immediately 
after training till about 24 hours later. Because scopola-
mine, as an impairing substance could deteriorate learn-
ing and memory in our essay, it seems reasonable to 
suggest that intra-CA1 agmatine microinjection does not 
affect water maze place learning. However to increase 
the accuracy of this study, in another experiment, ag-
matine was injected immediately after training to test its 
effect mainly on consolidation process. Although again 
post training scopolamine treatment impaired memory, 
post training agmatine administration had no effect on 
animal's memory. 
Compatible  with  our  results,  McKay  et  al.
8 
showed that agmatine (ip) did not affect water maze 
performance.  In  contrast,  Liu  et  al.
10  reported  that 
agmatine can affect water maze reference memory in 
a dose dependent manner; low dose agmatine (10 µg, 
icv)  improved  memory,  while  high  dose  agmatine 
(100 µg icv) produced impairment. The authors sug-
gested  that  agmatine  affects  water  maze  reference 
memory  in  a  dose  dependent  manner.  Our  study 
showed that agmatine administration to CA1 region 
of the hippocampus -in a wide range of doses- can not 
affect water maze reference memory. As CA1 is the 
last station of hippocampal synaptic loops, possibly 
agmatine has no effect on hippocampal function by 
itself.  Interestingly,  our  recent  study
17  showed  that 
agmatine  can  protect  hippocampus  against  LPS-
induced spatial memory impairement and apoptosis. 
In that study periepheral agmatine administration (in 
doses 5 and 10 mg/kg) did not affect water maze per-
formance, while it protected the animals against water 
maze place navigation and hippocampal apoptosis. It 
was interesting for us to know if agmatine can affect 
hippocampal function in dose ranges wider than what 
we used in previous study. Then this study was de-
signed to administer agmatine into CA1 area to know 
agmatine's direct effect on the hippocampus. 
There  are  also  some  other  experiments  demon-
strating the impairing effect of agmatine on learning 
and memory. For example it was shown that contextual 
fear conditioning and learning were impaired by ag-
matine (ip).
7,8 Although both contextual fear and wa-
ter maze learning are dependent on the hippocampus, 
it  is  suggested  that  water  maze  learning  requires  the 
physiologic integrity of dorsal hippocampus,
18,19 where-
as contextual  fear  learning  appears  to  be  based  upon 
ventral hippocampal functioning.
 19,20 Also, Otake et al.
4 
who  showed  agmatine  immunoblotting  at  numerous 
central  sites  have  proposed  that  the  highest  agmatine 
concentration may be within subiculum (ventral hippo-
campus). As expected in our study, the cannulas were 
implanted in dorsal hippocampal CA1 regions. 
Arteni et al.
9 found that agmatine (ip) facilitates 
memory  consolidation  in  the  inhibitory  avoidance 
task.  The  systems  and  mechanisms  responsible  for 
passive avoidance task and water maze could be dif-
ferent. The structure which is more involved in in-
hibitory avoidance task is amygdale.
21 Amygdala re-
ceives its major excitatory inputs from locus coerule-
us  which  is  the  principal  source  of  agmatine-
containing cell bodies in the medulla oblongata.
4 Also 
Ruis-Duranetz et al.
22 demonstrated that agmatine icv 
infusion at doses of 10, 20 and 40 µg increased the 
firing rate of locus coeuleus neurons in a dose de-
pendent manner.  
In conclusion, our findings are the first report in-
dicating that intra-CA1 agmatine administration in a 
broad  range  of  doses  has  no  effect  on  water  maze 
learning and memory. It will be valuable in the future 
to  know  more  about  the  effect  of  agmatine  on  the 
hippocampal function and mechanisms in physiologic 
and pathologic states as there are increasing evidenc-
es  that  agmatine  is  protective  against  some  neuro-
degenerative disorders. 
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